Director TitleAgeSince
Director/Board Member - -
Director/Board Member - 2013-09-26
Chairman - -
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-20.59% - - 23.15M
-6.60%-10.93%+45.08%+60.01% 68.98B
-4.09%+3.12%+3.71%+53.50% 53.15B
+0.03%+7.21%+12.52%+44.46% 50.83B
-1.53%+3.10%+31.40%+33.88% 44.61B
-5.97%-5.40%+259.08%+494.98% 40.57B
-1.34%+5.41%+16.74%+106.42% 42.53B
+6.53%+8.02%+18.98%+54.58% 30.95B
-0.90%-10.91%+34.11%-1.83% 25.44B
-2.76%-4.73%-15.94%-15.32% 22.66B
Average -1.54%+1.52%+45.08%+92.30% 42.19B
Weighted average by Cap. -2.43%+1.65%+46.51%+96.53%
Logo Pharmadax Inc.
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4191 Stock